Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
22.26
-0.88 (-3.80%)
At close: Aug 12, 2026, 4:00 PM EDT
22.50
+0.24 (1.08%)
After-hours: Aug 12, 2026, 4:10 PM EDT

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
6,2917,623---
Market Cap Growth
-23.92%----
Enterprise Value
5,9507,201000
Last Close Price
22.2626.98---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
77.91294.73---
PS Ratio
6.369.39---
PB Ratio
11.052.44---
P/TBV Ratio
2.071.45---
P/FCF Ratio
50.74113.95---
P/OCF Ratio
37.3191.67---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.018.87---
EV/EBITDA Ratio
34.18106.33---
EV/EBIT Ratio
38.81159.63---
EV/FCF Ratio
47.99107.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.130.12-1.15-8.460.67
Debt / EBITDA Ratio
2.265.60---
Debt / FCF Ratio
3.175.67---
Net Debt / Equity Ratio
-0.13-0.13-0.12-0.020.11
Net Debt / EBITDA Ratio
-2.30-6.22-1.50-0.150.72
Net Debt / FCF Ratio
-3.23-6.29-1.23-0.140.58
Asset Turnover
0.841.111.090.540.36
Inventory Turnover
-13.795.274.523.80
Quick Ratio
4.757.170.941.903.31
Current Ratio
5.537.851.302.553.77
Return on Equity (ROE)
-0.04%-4.78%189.92%-293.83%-127.28%
Return on Assets (ROA)
13.00%6.14%-67.96%-56.54%-44.01%
Return on Invested Capital (ROIC)
5.63%3.13%-103.66%-168.80%-518.91%
Return on Capital Employed (ROCE)
15.05%7.67%-103.66%-71.15%-54.39%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
FCF Yield
1.97%0.88%---
Buyback Yield / Dilution
-559.05%-371.04%-1.59%-4.73%-
Total Shareholder Return
-559.05%-371.04%-1.59%-4.73%-
SEC Filings: 10-K · 10-Q